Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | MEDICAL EQUIPMENT AND ENGG COMPANYLikely | 1 | ₹11,628 |
| 2 | Schedule 2 | MAHAVIR PHARMACEUTICALSLikely | 1 | ₹330 |
| 3 | Schedule 3 | Not yet disclosed by govt.Likely | 55 | - |
| 4 | Schedule 4 | SUNIL PHARMACYLikely | 1 | ₹6,264 |
| 5 | Schedule 5 | KUNDAN LIFESCIENCESLikely | 1 | ₹8,247.60 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
8 Sept 2025, 10:00 amClosed
CHLORHEXIDINE MOUTH WASH
CHLORPROMAZINE 25 MG TAB
CILNIDIPINE 10 MG TAB
COVER GLASS STRIPS
CYCLOSPORINE 25MG TAB
EVEROLIMUS 0 point 5 MG TAB
INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII
INJ DARBEPOETIN 25 MG
INJ OCTREOTIDE 20 MG
INJ PNEUMOCOCAL VACCINE 23
KIT FOR ESTIMATION OF CHOLESTROL
MESALAMINE 1 GM SACHE
METHOTREXATE 10MG TAB
METOLAZONE 5MG TAB
MICRO TIPS 100 to 1000 UL PKT OF 1000
MICRO TIPS 5 to 50 UL PKT OF 1000
OLANZAPINE 2 point 5 MG TAB
OLMESARTAN 40 plus HCTZ 12 point 5 MG TAB
SOTALOL 40 MG TAB
SYP IRON plus FOLIC ACID
ACEBROPHYLLIN 200 MG plus FEXOFENADINE
ACECLOFENAC 100 MG plus THIOCOLCHICOSIDE
ACITRETIN 10 MG TAB
ASPIRIN 75 MG plus ATORVASTATIN 10
ATORVASTATIN 80 MG TAB
BETAHISTINE 24 MG TAB
BUDESONIDE 500 MCG plus FORMOTEROL 20 MCG RESPULES
CARBAMAZEPINE 100 MG TAB
CARBAMAZEPINE 400 MG CR TAB
CARBIDOPA 18 point 75 plus LEVODOPA 75 MG
CHOLINE SALICYLATE 8 point 7 percent plus LIDOCAINE
CILNIDIPINE 20 MG TAB
CILOSTAZOL 50MG TAB
CINNARIZINE 75 MG TAB
CIPROFLOXACIN TINIDAZOLE
CLOPIDOGREL TAB ASPIRIN 75 MG TAB
CLOTRIMAZOLE EAR DROPS
DAPAGLIFLOZIN 5 MG plus METFORMIN 500 MG TAB
DEFLAZACORT 12 MG TAB
DESVENLAFAXINE 25 MG TAB
DESVENLAFAXINE 75 MG TAB
DEXAMETHASONE 0 point 5MG TAB
DULOXETINE 10 TAB
EMPAGLIFLOZIN 5MG plus METFORMIN 500MG TAB
ENALAPRIL 10MG TAB
CAPESITABINE 400MG plus CYCLOPHOSPHAMIDE 20MG TAB
CAPESITABINE 700MG 20MG TAB CYCLOPHOSPHAMIDE 30MG TAB
METHYLCOBALAMIN 1500 MCG 20MG plus ALPHA LIPOIC ACID
TOLPERISONE SR 150 MG TAB
BETAMETHASONEplusNEOMYCINplusCLOTRI MAZOLE CREAM
TAB SODIUM VALPROATE 500 MG CR SODIUM VALPROATE Bid Details 2/42
8157087
GEM/2025/B/6512578
Two Packet Bid
CHLORHEXIDINE MOUTH WASH
28 days
Punjab; Jalandhar
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹10 L
₹15 L
80%
Exempted
8 Sept 2025
18 Aug 2025
8 Sept 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | CHLORHEXIDINE MOUTH WASH | CHLORHEXIDINE MOUTH WASH 2 percent BOTT OF 100 ML | 1,140 | Bott | JALANDHAR CITY | 28 |
| 2 | CHLORPROMAZINE 25 MG TAB | CHLORPROMAZINE 25 MG TAB | 600 | No | JALANDHAR CITY | 28 |
| 3 | CILNIDIPINE 10 MG TAB | CILNIDIPINE 10 MG TAB | 5,26,800 | No | JALANDHAR CITY | 28 |
| 4 | COVER GLASS STRIPS | COVER GLASS STRIPS | 108 | No | JALANDHAR CITY | 28 |
| 5 | CYCLOSPORINE 25MG TAB | CYCLOSPORINE 25MG TAB | 1,740 | No | JALANDHAR CITY | 28 |
| 6 | EVEROLIMUS 0 point 5 MG TAB | EVEROLIMUS 0 point 5 MG TAB | 360 | No | JALANDHAR CITY | 28 |
| 7 | INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII | INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII | 180 | PFS | JALANDHAR CITY | 28 |
| 8 | INJ DARBEPOETIN 25 MG | INJ DARBEPOETIN 25 MG | 252 | PFS | JALANDHAR CITY | 28 |
| 9 | INJ OCTREOTIDE 20 MG | INJ OCTREOTIDE 20 MG | 6 | AMP | JALANDHAR CITY | 28 |
| 10 | INJ PNEUMOCOCAL VACCINE 23 | INJ PNEUMOCOCAL VACCINE 23 | 30 | PFS | JALANDHAR CITY | 28 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8157087.pdf
GEM_BID
docpic_2025-07-30-11-22-08_62f0a4e3f70c3a5b2ff3437f260b1369.pdf
BOQ
boq_item_sample_file-1_2025-07-30-11-22-08_6769cfc0b11466cefebe800e46740c25.csv
BOQ
ATC_59fdc45f-a3e9-4b22-bd471753855725737_USINGH1972.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .